| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |